FDA again bypasses advisers to remove black-box warnings from menopause treatments

Synopsis

Three more patches for treating menopause will no longer carry black-box warnings about cardiovascular disease, breast cancer and dementia, officials at the US Food and Drug Administration (FDA) said on Friday. Manufacturing of estrogen patches has doubled over the past year, she said.

Automatically extracted from the original page. This is a short summary, not the full story, and may omit important detail.